Showing results (71-80 of 296) with videos related to
Sort By:
Pageof 30
Nucleic Acids Research|September 11, 2019
Molecular determinants for enzalutamide-induced transcription in prostate cancerFuwen Yuan, William Hankey, Dayong Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysisAndrew J Armstrong, Elizabeth S Garrett-Mayer, Yi-Chun Ou Yang, et al.The Journal of Urology|July 25, 2017
Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs PlaceboMary-Ellen Taplin, Andrew J Armstrong, Ping Lin, et al.European Urology|December 4, 2012
New and emerging therapies for bone metastases in genitourinary cancersPhilip J Saylor, Andrew J Armstrong, Karim Fizazi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancerAndrew J Armstrong, Elizabeth Garrett-Mayer, Yi-Chun Ou Yang, et al.Clinical Genitourinary Cancer|February 25, 2015
Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate CancerTian Zhang, Mallika S Dhawan, Patrick Healy, et al.Cancer|March 3, 2011
The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapyGuru Sonpavde, Gregory R Pond, William R Berry, et al.Urologic Oncology|October 5, 2010
Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapyGuru Sonpavde, Gregory R Pond, William R Berry, et al.Methods (San Diego, Calif.)|July 13, 2013
Development of a method to isolate circulating tumor cells using mesenchymal-based captureRhonda L Bitting, Rengasamy Boominathan, Chandra Rao, et al.European Urology|October 27, 2015
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving DocetaxelGuru Sonpavde, Gregory R Pond, Arnoud J Templeton, et al.Pageof 30